Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 136

1.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.

Ghosn J, Bayan T, Meixenberger K, Tran L, Frange P, d'Arminio Monforte A, Zangerle R, de Mendoza C, Krastinova E, Porter K, Meyer L, Chaix ML; CASCADE Collaboration in EuroCoord.

J Antimicrob Chemother. 2017 Oct 1;72(10):2862-2868. doi: 10.1093/jac/dkx247.

PMID:
29091208
2.

Prevention of cervical cancer in HIV-seropositive women from developing countries: a systematic review protocol.

Mapanga W, Elhakeem A, Feresu SA, Maseko F, Chipato T.

Syst Rev. 2017 Apr 24;6(1):91. doi: 10.1186/s13643-017-0484-9.

3.

Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.

Schlusser KE, Konikoff J, Kirkpatrick AR, Morrison C, Chipato T, Chen PL, Munjoma M, Eshleman SH, Laeyendecker O.

AIDS Res Hum Retroviruses. 2017 Jun;33(6):555-557. doi: 10.1089/aid.2016.0245. Epub 2017 Mar 20.

PMID:
28318310
4.

Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.

Mangal TD; UNAIDS Working Group on CD4 Progression and Mortality Amongst HIV Seroconverters including the CASCADE Collaboration in EuroCoord.

AIDS. 2017 May 15;31(8):1073-1082. doi: 10.1097/QAD.0000000000001437.

5.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

6.

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.

Polis CB, Curtis KM, Hannaford PC, Phillips SJ, Chipato T, Kiarie JN, Westreich DJ, Steyn PS.

AIDS. 2016 Nov 13;30(17):2665-2683.

7.

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.

Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, Rwambuya S, Munjoma M, Chipato T, Byamugisha J, Van Der Pol B, Mugyenyi P, Salata RA, Morrison CS, Arts EJ.

EBioMedicine. 2016 Nov;13:305-314. doi: 10.1016/j.ebiom.2016.10.014. Epub 2016 Oct 12.

8.

Serum vitamin D status and bacterial vaginosis prevalence and incidence in Zimbabwean women.

Turner AN, Carr Reese P, Chen PL, Kwok C, Jackson RD, Klebanoff MA, Fichorova RN, Chipato T, Morrison CS.

Am J Obstet Gynecol. 2016 Sep;215(3):332.e1-332.e10. doi: 10.1016/j.ajog.2016.02.045. Epub 2016 Mar 2.

9.

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.

AIDS Res Hum Retroviruses. 2016 May;32(5):443-51. doi: 10.1089/AID.2015.0088. Epub 2016 Jan 26.

10.

A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.

Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S; WHO Study Group on Contraceptive Implants for Women.

Hum Reprod. 2015 Nov;30(11):2527-38. doi: 10.1093/humrep/dev221. Epub 2015 Sep 25.

11.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

12.

HIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013-March 2014.

Simmons R, Malyuta R, Chentsova N, Medoeva A, Kruglov Y, Yurchenko A, Copas A, Porter K; CASCADE Collaboration in EuroCoord.

PLoS One. 2015 Aug 31;10(8):e0137062. doi: 10.1371/journal.pone.0137062. eCollection 2015.

13.

Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.

Maternowska MC, Mashu A, Moyo P, Withers M, Chipato T.

Reprod Health Matters. 2015 Feb;22(44 Suppl 1):16-25. doi: 10.1016/S0968-8080(14)43792-3.

14.

Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women.

Napierala Mavedzenge S, Müller EE, Lewis DA, Chipato T, Morrison CS, Weiss HA.

J Infect Dis. 2015 May 1;211(9):1388-98. doi: 10.1093/infdis/jiu644. Epub 2014 Nov 17.

PMID:
25404521
15.

Cessation of intravaginal practices to prevent bacterial vaginosis: a pilot intervention in Zimbabwean women.

Esber A, Moyo P, Munjoma M, Francis S, van de Wijgert J, Chipato T, Turner AN.

Sex Transm Infect. 2015 May;91(3):183-8. doi: 10.1136/sextrans-2014-051764. Epub 2014 Oct 29.

PMID:
25355772
16.

Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.

Woodsong C, Musara P, Chandipwisa A, Montgomery E, Alleman P, Chirenje M, Chipato T, Martinson F, Hoffman I.

BJOG. 2014 Oct;121 Suppl 5:45-52. doi: 10.1111/1471-0528.12875.

17.

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

Naranbhai V, Moodley D, Chipato T, Stranix-Chibanda L, Nakabaiito C, Kamateeka M, Musoke P, Manji K, George K, Emel LM, Richardson P, Andrew P, Fowler M, Fletcher H, McShane H, Coovadia HM, Hill AV; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):573-5. doi: 10.1097/QAI.0000000000000353.

18.

Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C.

Mutsvangwa J, Beck IA, Gwanzura L, Manhanzva MT, Stranix-Chibanda L, Chipato T, Frenkel LM.

J Virol Methods. 2014 Dec 15;210:36-9. doi: 10.1016/j.jviromet.2014.09.005. Epub 2014 Sep 17.

19.

Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.

Blanchard K, Chipato T, Ramjee G, Nhemachena T, Harper CC; Provider Study Writing Comittee.

Contraception. 2014 Oct;90(4):391-8. doi: 10.1016/j.contraception.2014.04.010. Epub 2014 May 4.

20.

Evaluation of rapid progressors in HIV infection as an extreme phenotype.

Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, Lodi S, Ghosn J, Dorrucci M, Johnson A, Sannes M, Moreno S, Porter K; for CASCADE Collaboration in EuroCoord.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):15-21. doi: 10.1097/QAI.0000000000000240.

Supplemental Content

Loading ...
Support Center